Lam Research Corporation $LRCX Shares Sold by MetLife Investment Management LLC

Key Points

• MetLife Investment Management LLC reduced its stake in Lam Research Corporation by 2.0%, holding 389,416 shares worth approximately $28.3 million after selling 7,802 shares.
• Several brokerages have demonstrated bullish sentiment on Lam Research, with a majority rating it as a Buy and price targets ranging from $98 to $125.
• The company reported a quarterly earnings per share (EPS) of $1.33, exceeding estimates, with a year-over-year revenue increase of 33.6%.

MetLife Investment Management LLC lessened its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 2.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 389,416 shares of the semiconductor company's stock after selling 7,802 shares during the quarter. MetLife Investment Management LLC's holdings in Lam Research were worth $28,311,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Smallwood Wealth Investment Management LLC acquired a new position in shares of Lam Research in the 1st quarter valued at $26,000. West Paces Advisors Inc. acquired a new position in shares of Lam Research in the 4th quarter valued at $27,000. Mpwm Advisory Solutions LLC acquired a new position in shares of Lam Research in the 4th quarter valued at $27,000. Park Square Financial Group LLC acquired a new position in shares of Lam Research in the 4th quarter valued at $31,000. Finally, Putney Financial Group LLC acquired a new position in shares of Lam Research in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 84.61% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on LRCX. The Goldman Sachs Group started coverage on shares of Lam Research in a report on Thursday, July 10th. They issued a "buy" rating and a $115.00 price target on the stock. TD Cowen raised their target price on shares of Lam Research from $100.00 to $125.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Needham & Company LLC raised their target price on shares of Lam Research from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. Wells Fargo & Company set a $98.00 target price on shares of Lam Research and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Finally, B. Riley reissued a "buy" rating and issued a $115.00 target price (up previously from $95.00) on shares of Lam Research in a research note on Wednesday, June 18th. Twenty equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $107.30.

Lam Research Stock Performance

Lam Research stock opened at $100.08 on Friday. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $108.02. The company has a market capitalization of $126.66 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 1.30 and a beta of 1.65. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. The firm's fifty day moving average price is $98.41 and its 200 day moving average price is $84.61.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. During the same quarter in the previous year, the firm posted $1.03 EPS. The firm's quarterly revenue was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.